FDA Grants Accelerated Approval to Sunvozertinib for Metastatic Non-Small Cell Lung Cancer with EGFR exon 20 Insertion Mutations By Ogkologos - July 25, 2025 263 0 Facebook Twitter Google+ Pinterest WhatsApp FDA also approved the Oncomine Dx Express Test as a companion diagnostic device Source RELATED ARTICLESMORE FROM AUTHOR ESMO Strengthens Global Oncology Collaboration Through its Growing Presence in the Asia-Pacific Pemigatinib Prolongs mPFS Over Chemotherapy in Patients with Advanced Cholangiocarcinoma with FGFR2 Fusions or Rearrangements FDA Approves Atezolizumab for Adjuvant Treatment of Muscle Invasive Bladder Cancer in Patients with Molecular Residual Disease MOST POPULAR EMA Recommends Extension of Indications for Durvalumab to Include Treatment of... March 28, 2025 Ibrutinib-Containing Immunochemotherapy in Front-Line Treatment of Young, Medically Fit Patients with... May 14, 2024 COVID-19 Vaccines: Considerations for Special Populations February 4, 2021 EMA Recommends Granting a Marketing Authorisation for Degarelix Accord September 14, 2023 Load more HOT NEWS Scientists reveal how air pollution can cause lung cancer in people... Woman Finds Out She Has Breast Cancer From Museum Photo Booth Significant OS Benefit with Glofitamab plus GemOx in Transplant-Ineligible Patients with... Obesity May Help Tumors Survive and Grow, Mouse Study Suggests
